A Complex Contraception Registry

Sponsor
University of California, San Diego (Other)
Overall Status
Completed
CT.gov ID
NCT02219269
Collaborator
University of California, Los Angeles (Other), University of California, San Francisco (Other), University of California, Irvine (Other), University of California, Davis (Other)
97
5
12
19.4
1.6

Study Details

Study Description

Brief Summary

The investigators will conduct a prospective observational cohort study to investigate factors that influence contraceptive method utilization among women with medical conditions. The investigators will also investigate how women with medical conditions access to contraception and family planning fellowship trained specialist. After the baseline questionnaire, there be a 3 month and 6 month follow up questionnaire to investigate continuation and satisfaction with the contraceptive method. This study is unique because it will allow us to explore doing collaborative family planning research at the multiple UC medical campuses.

Detailed Description

Many women with complex medical conditions who do not desire pregnancy do not receive contraception counseling from their primary or subspecialty care clinicians, and often they are not using contraception. This is an important deficiency as many have conditions that could worsen with pregnancy or for whom pregnancy can be complicated by the medical condition. Thus it is important for women with chronic disease to only become pregnant if they intend to do so. The United States Medical Eligibility Criteria for Contraceptive Use (USMEC), released in 2010, has greatly enhanced the ability of clinicians to counsel patient with complex medical conditions about their contraceptive options. It summarizes the safety of specific contraceptives when used on women with medical conditions. However, little is known about the contraceptive care of these women. We do not know if the availability of the USMEC has translated into evidence-based contraceptive counseling for these women. Further, little is known about their understanding of the interaction between their disease and pregnancy, their past experience and knowledge about contraception, and their contraceptive decision-making, satisfaction and continuation.

The purpose of the Complex Contraception Registry to is to recruit a cohort of women with complex medical conditions who are seen in contraception referral practices run by family planning fellowship trained physicians. We will assess their past experiences and baseline knowledge, their post-counseling experiences and choice of contraception, and their long-term satisfaction with and continuation of contraception. A multi-center registry is necessary because individual institutions see relatively few women with rare diseases such as a history of transplant surgery. The UC Family Planning Collaborative will facilitate recruitment of participants from the 5 UC medical campuses and will oversee their follow-up for one year.

Specific Aim include (1.) To investigate what factors influence contraceptive method utilization among women with complex medical conditions and their perceived risk of unintended pregnancy (2) To investigate how women with complex medical conditions access family planning fellowship trained specialist for contraception counseling and (3.) To assess satisfaction and continuation of contraceptive methods among women with complex medical conditions.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
97 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
A Complex Contraception Registry - UC Family Planning Collaborative Study
Actual Study Start Date :
Jun 1, 2014
Actual Primary Completion Date :
Jun 1, 2015
Actual Study Completion Date :
Jun 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Medically complex contraception users

Cohort includes women of reproductive age with diverse medical conditions (listed in inclusion criteria) who are referred to Family Planning felowship-trained physicians, seeking contraception counseling and administration.

Outcome Measures

Primary Outcome Measures

  1. Contraceptive method continuation and satisfaction [6 month]

    Questionnaire is used to report continued use and satisfaction with multiple choice answer: very satisfied, somewhat satisfied, dissatisfied. Questionnaires will be administered at 3 months and 6 months after recruitment.

Secondary Outcome Measures

  1. History of unintended pregnancy [6 months]

    Measured with questionnaire at baseline, 3 months, and 6 months

  2. Change in Medical Condition [6 months]

    Measured with questionnaire at 3 months and 6 months

  3. History of contraceptive methods used [6 months]

    Measured with questionnaire at baseline

  4. If Contraception is Accessed in post-partum or post-abortion setting [6 months]

    Measured with questionnaire at baseline, 3 months, and 6 months

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Ethnic Background: No limitation, will include minorities

  2. Sexually Active with men

  3. Diagnosis with at least one of the following conditions

  • Diabetes and other endocrine disorders

  • Cardiovascular Disease, such as Ischemic Heart Disease, Valvular disease, hypertension or pulmonary hypertension

  • Epilepsy, Migraine, and other neurologic disorders

  • History of or current cancer

  • History of or planning Bariatric Surgery

  • History of or planning Solid Organ Transplant

  • Systematic Lupus Erythematous and other rheumatologic conditions

  • History of or current Venous Thrombosis Embolism

  • Other Medical Conditions (such as Sickle Cell Disease or Cystic Fibrosis)

Exclusion Criteria:
  1. Pregnant at time of recruitment

  2. History of hysterectomy, bilateral oophorectomy, or sterilization procedure

  3. Unable to provide informed consent

  4. Attempting to become pregnant at time of recruitment

  5. Not sexually active with men

  6. No active telephone number or email for follow up

Women who are pregnant will be excluded from this study. However, no pregnancy testing will be conducted; pregnancy status will be based on self-reporting by subjects.

Contacts and Locations

Locations

Site City State Country Postal Code
1 UCLA Los Angeles California United States 90095
2 UC Irvine Orange California United States 92868
3 UC Davis Sacramento California United States 95817
4 UCSD San Diego California United States 92103
5 UCSF San Francisco California United States 94117

Sponsors and Collaborators

  • University of California, San Diego
  • University of California, Los Angeles
  • University of California, San Francisco
  • University of California, Irvine
  • University of California, Davis

Investigators

  • Principal Investigator: Jody Steinauer, MD, University of California, San Francisco
  • Principal Investigator: Radhika Rible, MD MS, University of California, Los Angeles
  • Principal Investigator: Tabetha Harken, MD MPH, UC Irvine
  • Principal Investigator: Catherine Cansino, MD MPH, UC Davis
  • Principal Investigator: Sheila Mody, MD MPH, UCSD

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Sheila Mody, Assistant Professor, University of California, San Diego
ClinicalTrials.gov Identifier:
NCT02219269
Other Study ID Numbers:
  • 140166
First Posted:
Aug 18, 2014
Last Update Posted:
Mar 14, 2018
Last Verified:
Mar 1, 2018
Keywords provided by Sheila Mody, Assistant Professor, University of California, San Diego
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 14, 2018